These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31775535)
1. Long-term safety, tolerability, and efficacy of magnesium valproate versus sodium valproate in acute seizures. Peng X; Yan Y; Chen R; Wang X; Xu X Curr Med Res Opin; 2020 Feb; 36(2):271-276. PubMed ID: 31775535 [No Abstract] [Full Text] [Related]
2. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Brigo F; Igwe SC Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639 [TBL] [Abstract][Full Text] [Related]
3. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US. Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977 [TBL] [Abstract][Full Text] [Related]
5. Topiramate monotherapy for juvenile myoclonic epilepsy. Liu J; Wang LN; Wang YP Cochrane Database Syst Rev; 2015 Dec; (12):CD010008. PubMed ID: 26695884 [TBL] [Abstract][Full Text] [Related]
6. Topiramate monotherapy for juvenile myoclonic epilepsy. Liu J; Wang LN; Wang YP Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010008. PubMed ID: 28434203 [TBL] [Abstract][Full Text] [Related]
7. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Christe W; Krämer G; Vigonius U; Pohlmann H; Steinhoff BJ; Brodie MJ; Moore A Epilepsy Res; 1997 Mar; 26(3):451-60. PubMed ID: 9127726 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial. Machado RA; García VF; Astencio AG; Cuartas VB Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525 [TBL] [Abstract][Full Text] [Related]
9. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. Richens A; Davidson DL; Cartlidge NE; Easter DJ J Neurol Neurosurg Psychiatry; 1994 Jun; 57(6):682-7. PubMed ID: 8006647 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the first antiepileptic drug in the treatment of pediatric epilepsy. Ma MS; Ding YX; Ying W; Fang F; Ding CH; Zou LP Pediatr Neurol; 2009 Jul; 41(1):22-6. PubMed ID: 19520269 [TBL] [Abstract][Full Text] [Related]
11. Treatment gaps of epilepsy and retention rates of sodium valproate in rural Guangxi, China. Huang DH; Zheng JO; Chen J; Yu L Genet Mol Res; 2014 Aug; 13(3):6202-12. PubMed ID: 25158247 [TBL] [Abstract][Full Text] [Related]
12. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison. Levisohn PM; Holland KD Epilepsy Behav; 2007 Jun; 10(4):547-52. PubMed ID: 17482520 [TBL] [Abstract][Full Text] [Related]
13. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. Temkin NR; Dikmen SS; Anderson GD; Wilensky AJ; Holmes MD; Cohen W; Newell DW; Nelson P; Awan A; Winn HR J Neurosurg; 1999 Oct; 91(4):593-600. PubMed ID: 10507380 [TBL] [Abstract][Full Text] [Related]
14. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Tudur Smith C; Marson AG; Williamson PR Cochrane Database Syst Rev; 2001; (4):CD001769. PubMed ID: 11687121 [TBL] [Abstract][Full Text] [Related]
15. Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects. Beenen LF; Lindeboom J; Kasteleijn-Nolst Trenité DG; Heimans JJ; Snoek FJ; Touw DJ; Adèr HJ; van Alphen HA J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):474-80. PubMed ID: 10486394 [TBL] [Abstract][Full Text] [Related]
16. Sodium valproate induced increased frequency of micturition and enuresis. Gosavi DD; Suman A; Jain M Indian J Pharmacol; 2013; 45(1):87-8. PubMed ID: 23543036 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group. Beydoun A; Sackellares JC; Shu V Neurology; 1997 Jan; 48(1):182-8. PubMed ID: 9008516 [TBL] [Abstract][Full Text] [Related]
18. Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307. Krauss GL; Perucca E; Kwan P; Ben-Menachem E; Wang XF; Shih JJ; Patten A; Yang H; Williams B; Laurenza A Epilepsia; 2018 Apr; 59(4):866-876. PubMed ID: 29574701 [TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391 [TBL] [Abstract][Full Text] [Related]
20. Effect of magnesium valproate on amygdala-kindled seizures in the rat: comparison with sodium valproate. Pallini R; Palestini M; Lauretti L; Rossi GF Neurol Res; 1989 Mar; 11(1):17-23. PubMed ID: 2565544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]